Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on reddit

Pharma falls on flu season failure

Demand for cough and cold remedies nearly non-existent
Dateline: 19 April 2022

In a strange twist of fate for the big pharma companies, their profits were sharply down in the first quarter, as the regular flu season turned out to be a damp squib.

It’s somewhat ironic that pharmaceutical giants that conquered Covid-19 with life-saving therapeutic drugs and vaccines, have now been ‘punished’ with a lack of demand for their seasonal remedies, that in the past were sure to pay dividends, year after year.

A young brand manager was delighted when his girlfriend recently caught a cold. “Quick, get out there and pass it around,” he begged. He was only half joking; his leading cough syrup was stuck on the shelves, gathering dust.

It seems that as people adjusted to life without shaking hands or casual kissing, normal virus transmission plummeted. On top of that, general hygiene has improved, globally, and people are far more conscious of healthy nutrition and regular exercise to boost their immunity. The co-morbidities that were such a big factor in causing coronavirus deaths, like obesity and poor vascular function, have fallen dramatically, meaning people are far less prone to disease. They’re generally, well, just healthier; and more robust.

Which is great news for medical aid and national health schemes; claims have fallen and reserves have been replenished, after they were decimated by the pandemic. But it’s bad news for the big pharma companies. They threw everything at Covid-19, and battered it into submission, even producing vaccines at cost or below, just to show their hearts were in the right place.

We’re eternally grateful, and loving our new, healthier lifestyles; but we’re not going to catch colds and flu if we can help it, just to bail out the drug companies. After all, they had it too good for too long, profiting off sick people. And there’s always the longevity market to pursue – that’s going to be worth trillions!

We learned a great lesson from the corona pandemic: Prevention is better than cure!

Links to related stories

Warning: Hazardous Thinking at Work

Despite appearances to the contrary, Futureworld cannot and does not predict the future. Our Mindbullets scenarios are fictitious and designed purely to explore possible futures, challenge and stimulate strategic thinking. Use these at your own risk. Any reference to actual people, entities or events is entirely allegorical. Copyright Futureworld International Limited. Reproduction or distribution permitted only with recognition of Copyright and the inclusion of this disclaimer. © Public domain image.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on LinkedIn
Share on pinterest
Share on Pinterest

Read another Mindbullet

From camera phone to plastic clone in three clicks
Dateline: 5 July 2015
It’s now a simple matter to create a bust of the company president or a replica of your favorite pet – just point, shoot a couple of times from different angles, and print it out in 3D; all from your camera phone of course, via the cloud. The SnapScan app from Autodesk for smartphones stitches...

Sign up to receive news from the future